Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001607062-17-000165
Filing Date
2017-04-28
Accepted
2017-04-28 16:19:18
Documents
53
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A rgbp123115form10qa2.htm 10-Q/A 291886
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7618
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 7655
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4365
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4304
  Complete submission text file 0001607062-17-000165.txt   2389331

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20151231.xml EX-101.INS 391623
7 XBRL SCHEMA FILE rgbp-20151231.xsd EX-101.SCH 26368
8 XBRL CALCULATION FILE rgbp-20151231_cal.xml EX-101.CAL 30443
9 XBRL DEFINITION FILE rgbp-20151231_def.xml EX-101.DEF 160864
10 XBRL LABEL FILE rgbp-20151231_lab.xml EX-101.LAB 134701
11 XBRL PRESENTATION FILE rgbp-20151231_pre.xml EX-101.PRE 187360
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

EIN.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 333-191725 | Film No.: 17795820
SIC: 2834 Pharmaceutical Preparations